Daniela de Florentiis

Author

Also Known As

D De Florentiis, D de Florentiis, D. de Florentiis, Daniela De Florentiis, Daniela de Florentiis, Daniela de Florentiis (745389), De Florentiis, D, De Florentis, Daniela

Publications

625

Citations

H-Index

Concepts

All Affiliations

University of Genoa Ospedale Policlinico San Martino Martin University Istituti di Ricovero e Cura a Carattere Scientifico Istituto Giannina Gaslini

About

Daniela de Florentiis is an author at University of Genoa specializing in medicine, vaccination, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	259
2	Epidemiology	5	5	143
3	Public Health	2	2	56
4	Health Sciences	1	1	72
5	Allergy	1	1	30

Daniela de Florentiis

Publications

442

Citations

H-Index

Page 1

	Year	Citations
Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study Matteo Bassetti, Maria Merelli, Filippo Ansaldi, PLoS ONE	2015	105
High-dose daptomycin in documented Staphylococcus aureus infections Matteo Bassetti, Elena Nicco, Francesca Ginocchio, International Journal of Antimicrobial Agents Antimicrobial SusceptibilityHealth SciencesAntibiotic AdjuvantHigh-dose DaptomycinInfection Control	2010	72
Molecular characterization of influenza B viruses circulating in northern Italy during the 2001–2002 epidemic season Filippo Ansaldi, Pierlanfranco D’Agaro, Daniela de Florentiis, Journal of Medical Virology	2003	45
Influenza vaccination in the elderly: why are the overall benefits still hotly debated? Cecilia Trucchi, Chiara Paganino, Andrea Orsi, PubMed VaccinationVaccine SafetyCross-protectionPreventive MedicineExact Magnitude	2015	35
Carriage of<i>Streptoccoccus pneumoniae</i>in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children Filippo Ansaldi, Daniela de Florentiis, Paola Canepa, Human Vaccines & Immunotherapeutics VaccinationVaccinologySerial Cross-sectional StudyReal-time PcrPediatrics	2013	30
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60 Filippo Ansaldi, Andrea Orsi, Daniela de Florentiis, Human Vaccines & Immunotherapeutics ImmunodeficienciesImmunologyImmunodominanceFlu VaccinationImmunotherapy	2013	30
Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses Filippo Ansaldi, Paola Canepa, Antonella Ceravolo, Vaccine VaccinationCross-protectionVaccine DevelopmentImmunologyVirology	2012	30
Increasing Incidence of <i>Streptococcus pneumoniae</i> Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine Filippo Ansaldi, Paola Canepa, Daniela de Florentiis, Clinical and Vaccine Immunology VaccinationVaccine SafetyReverse VaccinologyVaccine DevelopmentVaccine Research	2010	27
Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy Filippo Ansaldi, Daniela de Florentiis, Paola Canepa, Vaccine VaccinationLong-lasting CoveragePreventive MedicineHealthcare-associated InfectionClinical Infection	2012	21
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine vs. standard-dose intramuscular vaccine in HIV-1-infected adults Filippo Ansaldi, Laura Valle, Daniela de Florentiis, Human Vaccines & Immunotherapeutics VaccinationVaccine SafetyHiv-1-infected AdultsNeurovirologyPhase 4	2012	14

Page 1